Myriad Genetics
MYGN
$18.18
Share price
1.11%
Change (1 day)
-14.61%
Change (1 year)
Myriad Genetics (MYGN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.36 B
According to Myriad Genetics's latest financial reports the company's total liabilities are $0.36 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | 16.11% |
| 2022-12-31 | $0.31 B | -11.33% |
| 2021-12-31 | $0.35 B | |
| 2020-06-30 | $0.48 B | 2.66% |
| 2019-06-30 | $0.47 B | 126.48% |
| 2018-06-30 | $0.20 B | -52.55% |
| 2017-06-30 | $0.44 B | 233.01% |
| 2016-06-30 | $0.13 B | 27.19% |
| 2015-06-30 | $0.10 B | -0.67% |
| 2014-06-30 | $0.10 B | 39.31% |
| 2013-06-30 | $75.22 M | 36.84% |
| 2012-06-30 | $54.97 M | 24.84% |
| 2011-06-30 | $44.03 M | 21.42% |
| 2010-06-30 | $36.26 M | 12.74% |
| 2009-06-30 | $32.16 M | -56.34% |
| 2008-06-30 | $73.68 M | 109.47% |
| 2007-06-30 | $35.17 M | 31.15% |
| 2006-06-30 | $26.82 M | 15.19% |
| 2005-06-30 | $23.28 M | 54.41% |
| 2004-06-30 | $15.08 M | -22.01% |
| 2003-06-30 | $19.33 M | -32.2% |
| 2002-06-30 | $28.52 M | -12.47% |
| 2001-06-30 | $32.58 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $34.38 B | 9,365.18% | 🇺🇸 USA |
 Exact Sciences EXAS | $3.32 B | 815.51% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 420.24% | 🇺🇸 USA |
 Biocept
BIOC | $21.81 M | -94.00% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $3.55 B | 879.34% | 🇺🇸 USA |